Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) – Global Forecasts to 2021 to 2026

$3,850.00$5,850.00

Published on: March 23, 2021
Clear
SKU: GMS-3073 Category:

OVERVIEW

The Global Pain Management Devices Market is expected to expand at a CAGR of 7.44% during the forecast period, amid the pandemic. Demand for Pain Management Devices Ma is driven by factors such as increased demand for long-term pain relief among the geriatric population, adverse effects of pain medications, development of a novel pain management system, current reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and highly validated efficacy of pain management devices for chronic pain treatment. COVID-19 will also be considered as a significant market contributor in the report.

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 1

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 2

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 3

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 4

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 5

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 6

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 7

Pain Management Devices Market by Mode of Purchase (Prescription-Based, OTC), by Device Type (Infusion Pumps, Neurostimulation, SCS, TENS, RF Ablation), Application (Migraine, Cancer, Neuropathy, Musculoskeletal, Facial) - Global Forecasts to 2021 to 2026 8

TABLE OF CONTENT

1 Global Pain Management Devices Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Pain Management Devices Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Pain Management Devices Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Pain Management Devices Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Pain Management Devices Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Pain Management Devices Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Pain Management Devices Market – By Type (Market Size – & million/billion)
8.1 Ablation Devices
8.2 Analgesic Infusion Pumps
8.3 Neuromodulation Devices

9 Global Pain Management Devices Market – By Mode of Purchase
9.1 Prescription-based Devices
9.2 Over-the-counter Devices

10 Global Pain Management Devices Market – By Application
10.1 Facial Pain and Migraine
10.2 Musculoskeletal Pain
10.3 Neuropathic Pain
10.4 Cancer Pain
10.5 Others

11 Global Pain Management Devices Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Pain Management Devices Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Pain Management Devices Market -Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Medtronic PLC
13.3 Smiths Medical
13.4 B. Braun Melsungen AG
13.5 Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
13.6 Becton, Dickinson and Company
13.7 ST. Jude Medical, Inc.
13.8 Boston Scientific Corporation
13.9 Hospira, Inc. (A Subsidiary of Pfizer Inc.)
13.10 Halyard Health, Inc.
13.11 Nevro Corp.
13.12 Company 11 & more

14 Global Pain Management Devices Market – Appendix
14.1 Sources
14.2 Abbreviations